Catalyst Wire Dossier Catalyst Wire Dossier

OZ1

anti-HIV-1 ribozyme OZ1 · Janssen-Cilag Pty Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OZ1, covering 2016-06-20 to 2018-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial [Phase 2]

See pricing